• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解新冠疫情期间传染病的非常规再次出现。

Understanding the unconventional reemergence of epidemics during the COVID-19 pandemic.

作者信息

Liu Bingjie, Xu Lina, Wang Yuqing, Hao Chuangli, Jiang Wujun

机构信息

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

出版信息

Transl Pediatr. 2025 Mar 31;14(3):473-479. doi: 10.21037/tp-24-482. Epub 2025 Mar 26.

DOI:10.21037/tp-24-482
PMID:40225082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11982997/
Abstract

Since the implementation of coronavirus disease 2019 (COVID-19) restrictions since 2020, the number of () infections in children has significantly decreased. However, after the end of the COVID pandemic, there has been a notable resurgence in infections, which is particularly unusual in terms of both the number of infections and their severity. The purpose of this article is to review the existing evidence and explore theories that underlying the epidemiological shifts of following the COVID-19 pandemic, and propose factors contributing to the unconventional resurgence of infections. Proposed factors include decline of immunity, circulation of different genetic types and emergence of new macrolide-resistant (MRMP) variants, immune dysregulation following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and others. Among these factors, the decline in immunity and the circulation of different genetic types are considered significant contributors. Further research in bacterial genomics and more robust immunology studies are needed to guide the prevention of infections and the allocation of healthcare resources. International cooperation and information sharing are crucial for understanding the epidemiological changes of . Further cross-regional collaboration is called to enhance our understanding of the scope of outbreaks and facilitate a collective response.

摘要

自2020年实施2019冠状病毒病(COVID-19)防控措施以来,儿童[具体病原体名称未给出]感染病例数显著下降。然而,在COVID大流行结束后,[具体病原体名称未给出]感染出现了显著反弹,无论是感染数量还是严重程度都尤为异常。本文旨在回顾现有证据,探讨COVID-19大流行后[具体病原体名称未给出]流行病学转变背后的理论,并提出导致[具体病原体名称未给出]感染非常规反弹的因素。提出的因素包括[具体病原体名称未给出]免疫力下降、不同基因类型的传播以及新的大环内酯耐药[具体病原体名称未给出](MRMP)变体的出现、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后的免疫失调等。在这些因素中,[具体病原体名称未给出]免疫力下降和不同基因类型的传播被认为是重要因素。需要在细菌基因组学方面开展进一步研究,并进行更有力的免疫学研究,以指导[具体病原体名称未给出]感染的预防和医疗资源的分配。国际合作和信息共享对于了解[具体病原体名称未给出]的流行病学变化至关重要。呼吁进一步开展跨区域合作,以加深我们对[具体病原体名称未给出]疫情范围的了解,并促进共同应对。

相似文献

1
Understanding the unconventional reemergence of epidemics during the COVID-19 pandemic.理解新冠疫情期间传染病的非常规再次出现。
Transl Pediatr. 2025 Mar 31;14(3):473-479. doi: 10.21037/tp-24-482. Epub 2025 Mar 26.
2
Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic.中国广州在新冠大流行后出现肺炎支原体感染爆发。
Virol J. 2024 Aug 11;21(1):183. doi: 10.1186/s12985-024-02458-z.
3
Synergistic impact of macrolide resistance and H3N2 infection on outbreak in children.大环内酯类耐药性与H3N2感染对儿童疫情的协同影响。
Microbiol Spectr. 2025 Apr;13(4):e0184424. doi: 10.1128/spectrum.01844-24. Epub 2025 Feb 25.
4
Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.美国俄亥俄州新冠疫情后儿童中的大环内酯类耐药肺炎支原体感染
Emerg Infect Dis. 2025 Mar;31(3):555-558. doi: 10.3201/eid3103.241570.
5
Reemergence of Mycoplasma pneumoniae disease: Pathogenesis and new approaches.肺炎支原体病的再发:发病机制与新方法。
Microb Pathog. 2024 Nov;196:106944. doi: 10.1016/j.micpath.2024.106944. Epub 2024 Sep 14.
6
Mycoplasma pneumoniae among Chinese Outpatient Children with Mild Respiratory Tract Infections during the Coronavirus Disease 2019 Pandemic.2019 年冠状病毒病大流行期间,中国门诊轻症呼吸道感染患儿中的肺炎支原体。
Microbiol Spectr. 2022 Feb 23;10(1):e0155021. doi: 10.1128/spectrum.01550-21. Epub 2022 Feb 9.
7
Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.儿童大环内酯类耐药肺炎支原体肺炎诊断与治疗专家共识。
World J Pediatr. 2024 Sep;20(9):901-914. doi: 10.1007/s12519-024-00831-0. Epub 2024 Aug 14.
8
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to and co-infecting respiratory viruses in Arkansas.由于 SARS-CoV-2 大流行,阿肯色州采取了非药物干预措施,暂时减少了儿童感染 和合并感染呼吸道病毒的病例。
Microbiol Spectr. 2024 Apr 2;12(4):e0290823. doi: 10.1128/spectrum.02908-23. Epub 2024 Mar 15.
9
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study.新冠疫情限制措施后肺炎支原体再度出现的全球时空动态:一项流行病学与传播建模研究
Lancet Microbe. 2025 Apr;6(4):101019. doi: 10.1016/j.lanmic.2024.101019. Epub 2025 Feb 27.
10
Trends in infections in pediatric patient preceding, during, and following the COVID-19 pandemic: a comprehensive longitudinal analysis.2019年冠状病毒病大流行之前、期间和之后儿科患者的感染趋势:一项全面的纵向分析。
Microbiol Spectr. 2025 Feb 4;13(2):e0100124. doi: 10.1128/spectrum.01001-24. Epub 2025 Jan 14.

本文引用的文献

1
Unravelling distinct patterns of metagenomic surveillance and respiratory microbiota between two P1 genotypes of .揭示两种P1基因型之间宏基因组监测和呼吸道微生物群的不同模式。 (注:原文句末不完整,推测补充完整后可能是这样的翻译)
Emerg Microbes Infect. 2025 Dec;14(1):2449087. doi: 10.1080/22221751.2024.2449087. Epub 2025 Jan 13.
2
Analysis of the potentially pathogenic bacteria of lower respiratory tract infections in children per-, during and post-COVID-19: a retrospective study.新冠疫情期间及前后儿童下呼吸道感染潜在致病菌分析:一项回顾性研究
Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):167-180. doi: 10.1007/s10096-024-04991-9. Epub 2024 Nov 18.
3
Epidemiology of respiratory pathogens in patients with acute respiratory infections during the COVID-19 pandemic and after easing of COVID-19 restrictions.
COVID-19 大流行期间和放宽 COVID-19 限制后急性呼吸道感染患者中呼吸道病原体的流行病学。
Microbiol Spectr. 2024 Nov 5;12(11):e0116124. doi: 10.1128/spectrum.01161-24. Epub 2024 Sep 25.
4
Epidemiologic trends and changes in humoral immunity and lymphocyte subsets levels among hospitalized children with Mycoplasma pneumoniae infection during 2019-2023.2019-2023 年期间住院的肺炎支原体感染患儿体液免疫和淋巴细胞亚群水平的流行病学趋势和变化。
Eur J Clin Microbiol Infect Dis. 2024 Sep;43(9):1837-1845. doi: 10.1007/s10096-024-04901-z. Epub 2024 Jul 18.
5
Evidence of immunity gap: Decline in antibodies against M. pneumoniae during the COVID-19 pandemic.免疫差距的证据:新冠疫情期间抗肺炎支原体抗体下降。
J Infect. 2024 Aug;89(2):106209. doi: 10.1016/j.jinf.2024.106209. Epub 2024 Jun 18.
6
Epidemic features and megagenomic analysis of childhood post COVID-19 pandemic: a 6-year study in southern China.儿童新冠大流行后(post-COVID-19 pandemic)的流行特征和巨基因组学分析:中国南方的一项为期 6 年的研究。
Emerg Microbes Infect. 2024 Dec;13(1):2353298. doi: 10.1080/22221751.2024.2353298. Epub 2024 Jun 27.
7
Novel Variant and Known Mutation in 23S rRNA Gene of Mycoplasma pneumoniae, Northern Vietnam, 2023.2023年越南北方肺炎支原体23S rRNA基因的新型变异和已知突变
Emerg Infect Dis. 2024 May;30(5):1034-1036. doi: 10.3201/eid3005.231632. Epub 2024 Apr 4.
8
Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China.中国大环内酯类耐药流行克隆株导致支原体肺炎的再现。
Lancet Microbe. 2024 Jun;5(6):e515. doi: 10.1016/S2666-5247(23)00405-6. Epub 2024 Jan 17.
9
Characterising respiratory infections among hospitalised children during the COVID-19 pandemic in southeastern China: a cross-sectional study of pathogens and clinical association.描述 COVID-19 大流行期间中国东南部住院儿童的呼吸道感染特征:病原体和临床关联的横断面研究。
BMJ Open. 2024 Jan 9;14(1):e076824. doi: 10.1136/bmjopen-2023-076824.
10
Bacterial nasopharyngeal colonisation in children in South Africa before and during the COVID-19 pandemic: an observational study.南非儿童在 COVID-19 大流行前后的鼻咽细菌定植:一项观察性研究。
Lancet Microbe. 2024 Jan;5(1):e34-e42. doi: 10.1016/S2666-5247(23)00260-4. Epub 2023 Dec 1.